Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1999
10/26/1999US5972377 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
10/26/1999US5972370 Peptide/protein suspending formulations
10/26/1999US5972369 Includes reservoir comprising beneficial agent and capillary channel in communication with reservoir and exterior of system for delivering beneficial agent from system
10/26/1999US5972358 A hydroalcohol detackifying mixture consist of stearoxy trimethylsilane, cetyl lactate, cyclomethicone, c12-c15 alkyl lactate and alcohol selected from ethanol, propanol, isopropanol and water; topical skin care products
10/26/1999US5972355 Stable water-containing cosmetic or pharmaceutical compositions which comprise biologically active agent and enzyme-based oxygen-scavenging antioxidant system
10/26/1999US5972349 Synthesis of polyribosylribitol phosphate oligosaccharides
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972328 Inhibiting amyloid deposition by administering glycerol trisulfuric acid or pharmaceutically acceptable salt
10/26/1999US5972317 Nail-permeable medication means is disclosed for delivering a medicament through nails, claws, hoofs, or other similar hardened tissue of dermal derivation; includes proteolytic enzyme and drug selected to treat specific disease
10/21/1999WO1999053027A1 Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999052946A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis
10/21/1999WO1999052858A2 Lipids
10/21/1999WO1999052562A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/21/1999WO1999052561A1 Inhibition of xenoreactive antibodies
10/21/1999WO1999052560A1 Comb copolymers for regulating cell-surface interactions
10/21/1999WO1999052559A1 OPHTHALMIC COMPOSITION COMPRISING A β-BLOCKER
10/21/1999WO1999052558A1 Controlled release tablet produced from linear water-insoluble polysaccharides
10/21/1999WO1999052557A1 Glycolipid creams
10/21/1999WO1999052550A1 Polymer particle vaccine delivery system
10/21/1999WO1999052549A1 Adjuvant compositions
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052529A1 Antioxidant stabilizer system for pharmaceutical formulations
10/21/1999WO1999052523A2 Flutamide compositions and preparations
10/21/1999WO1999052512A1 Coated starch capsules and a process for producing them
10/21/1999WO1999052511A1 Tarch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
10/21/1999WO1999052510A1 Wettable microcapsules having hydrophobic polymer coated cores
10/21/1999WO1999052507A1 Incorporation of active substances in carrier matrixes
10/21/1999WO1999052506A1 Particulate active agent support for pulmonary application
10/21/1999WO1999052495A1 External preparations for treating dry skin
10/21/1999WO1999046245A3 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
10/21/1999WO1999044573B1 Composition and means for treating dry mouth
10/21/1999WO1999040113A9 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
10/21/1999WO1999039707A8 Metal-thiols as immunomodulating agents
10/21/1999WO1999036105A9 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
10/21/1999WO1999033522A8 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer
10/21/1999DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/21/1999DE19848597A1 Stabilized compositions useful for stimulating collagen neogenesis in treatment of bone defects
10/21/1999DE19816665A1 Glycolipid-Cremes Glycolipid creams
10/21/1999CA2340340A1 Particulate excipients for pulmonary administration
10/21/1999CA2328465A1 Glycolipid creams
10/21/1999CA2327883A1 Slow-release tablet prepared from linear water-insoluble polysaccharides
10/21/1999CA2327882A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999CA2327708A1 Antioxidant stabilizer system for pharmaceutical formulations
10/21/1999CA2326618A1 Inhibition of xenoreactive antibodies
10/21/1999CA2325939A1 Vaccine
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2324364A1 Starch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
10/21/1999CA2324363A1 Coated starch capsules and a process for producing them
10/20/1999EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999EP0950410A1 Conjugated linoleic acid compositions
10/20/1999EP0950408A1 Oily patches for external use containing diclofenac sodium
10/20/1999EP0950404A2 Process for preparation of solid dosage forms
10/20/1999EP0950403A2 Emulsions for in-situ delivery systems
10/20/1999EP0950402A2 Chewable pharmaceutical composition with gelatin matrix
10/20/1999EP0950401A2 Cosmetic and/or pharmaceutical W/O emulsions comprising an alpha-omega oxyalkylated substituted silicone
10/20/1999EP0949932A1 Use of hollow microcapsules in diagnosis and therapy
10/20/1999EP0949929A1 Use of plant extract for inhibition of haemophilus influenzae
10/20/1999EP0949927A2 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
10/20/1999EP0949923A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
10/20/1999EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999EP0949911A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer
10/20/1999EP0949909A1 Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
10/20/1999EP0949907A1 Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
10/20/1999EP0949905A2 Injectable depot gel composition and method of preparing the composition
10/20/1999EP0831867A4 Collagen-based delivery matrix
10/20/1999EP0767659B1 Transdermal administration of oxybutynin
10/20/1999EP0766689B1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof
10/20/1999CN1232470A GLP-1 derivs.
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232394A Solid oral dosage forms of valsartan
10/20/1999CN1232391A Pharmaceutical microspheres of valproic acid for oral administration
10/20/1999CN1232386A Colonic delivery of weak acid drugs
10/20/1999CN1231918A Human immunization strengthening medicine
10/20/1999CA2269460A1 Hydroxy-methyl-hexanones
10/19/1999US5969126 GNRH-leukotoxin chimeras
10/19/1999US5969111 Radiation sensistizers
10/19/1999US5968987 In lipid-based formulations for oral and injectable use
10/19/1999US5968943 Derivatives of camptothecin and methods of treating cancer using these derivatives
10/19/1999US5968922 Gallium complexes of 3-hydroxy-4-pyrones to treat or prevent hypercalcemia
10/19/1999US5968919 Hormone replacement therapy drug formulations for topical application to the skin
10/19/1999US5968913 Pharmaceutical compositions of uridine triphosphate
10/19/1999US5968906 Sucralfate preparations
10/19/1999US5968899 Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
10/19/1999US5968895 Solid ionic complexes of luteinizing hormone releasing hormone analogues(active peptides) and anionic polymer carriers, also for stable suspensions or dispersions(not microencapsulated), for treatment of prostate cancer
10/19/1999US5968811 Extracting saccharomyces cerevisiae refuse with food-grade alkaline salt, separating lysed from whole cells, mixing disrupted walls with alkaline extraction agent, heating, bleaching and oxidizing, acidifying mixture
10/19/1999US5968553 Storage stability, shelf life
10/19/1999US5968550 Liquisolid systems and methods of preparing same
10/19/1999US5968549 Solubilisation aids
10/19/1999US5968542 Surgical implants; noncrystallizing carrier
10/19/1999US5968521 Conjugate vaccine for group B Streptococcus
10/19/1999US5968519 Antiinflammatory agents or analgesics in mammals
10/19/1999US5968518 Composition and method for treating premenstrual syndrome
10/19/1999US5968485 UV protection compositions
10/19/1999US5968477 Radiolabeled annexin conjugates with hexose and a chelator
10/19/1999CA2154913C Magnetically responsive composition for carrying biologically active substances and methods of production and use
10/14/1999WO1999051729A1 Pentaerythritol lipid derivatives
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051638A1 DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS
1 ... 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 ... 1712